Treatment of chronic myelogenous leukemia with the tyrosine kinase inhibitor STI571 results in marked regression of bone marrow fibrosis.
C. Beham-Schmid, U. Apfelbeck, H. Sill, O. Tsybrovsky +3 more
2002Blood128 citations Open access
Semantic Scholar

